This list is an analysis based on recent market events. It's not an investment recommendation.
Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.
FAQs
What is Lukas Biomedical stock price today?▼
The current price of 6814.TWO is TWD18.00 TWD — it has decreased by -3.74% in the past 24 hours. Watch Lukas Biomedical stock price performance more closely on the chart.
What is Lukas Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Lukas Biomedical stocks are traded under the ticker 6814.TWO.
Is Lukas Biomedical stock price growing?▼
6814.TWO stock has risen by +2.27% compared to the previous week, the month change is a -2.17% fall, over the last year Lukas Biomedical has showed a -35.71% decrease.
What is Lukas Biomedical market cap?▼
Today Lukas Biomedical has the market capitalization of 753.73M
What is Lukas Biomedical revenue for the last year?▼
Lukas Biomedical revenue for the last year amounts to 179.49M TWD.
What is Lukas Biomedical net income for the last year?▼
6814.TWO net income for the last year is -85.63M TWD.
How many employees does Lukas Biomedical have?▼
As of November 4, 2026, the company has 87 employees.
In which sector is Lukas Biomedical located?▼
Lukas Biomedical operates in the Health & Wellness sector.
When did Lukas Biomedical complete a stock split?▼
Lukas Biomedical has not had any recent stock splits.
Where is Lukas Biomedical headquartered?▼
Lukas Biomedical is headquartered in New Taipei, Taiwan.